Otonomy to Participate in the H.C. Wainwright BioConnect 2021 Virtual Conference

Back to Jobs

SAN DIEGO , Jan. 05, 2021 (GLOBE NEWSWIRE) — Otonomy , Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that management is scheduled to participate in a fireside chat at the virtual H.C.

Apply Now